PREmedico invites you to an OPEN Lecture
Discover how PentaBase and Amplexa Genetics are advancing personalized medicine. Learn about their innovative technologies for precise cancer mutation monitoring and targeted diagnostics, and how these solutions can transform healthcare through clinical and research collaborations.
PREmedico invites you to an OPEN Lecture
We are pleased to welcome PentaBase and Amplexa Genetics, who will provide insights into their work with solutions in personalised medicine and discuss how these can be integrated into the healthcare system through both clinical and research collaborations.
- PentaBase creates PCR technologies that allows for precise and personalized stratification and monitoring of cancer mutations and epigenetic changes.
- Amplexa Genetics develops laboratory-based technologies and tests that contribute to more targeted diagnostics and treatment.
Content:
In their presentations, PentaBase and Amplexa Genetics will share their perspectives on personalised medicine, from technological solutions to concrete applications in clinical practice and research. The focus will be on how their solutions can support existing workflows in hospitals and open up new forms of collaboration between the healthcare sector and private stakeholders.
The lectures will be followed by an opportunity for questions, discussion, and collective reflection.
Target Audience:
Members of PREmedico and colleagues with an interest in personalised medicine, healthcare innovation, and clinical research collaborations.
Date: Thursday, 23rd April 2026
Time: 15:30-17:00
Venue: OUH, Kløvervænget 6, Entrance 93, 5000 Odense C, Meeting Room 1+2, Ground Floor
Registration:
You can register for either physical or online participation. The registration deadline is 16th April 2026.
Sign up here!
Online participation:
You will receive a link for online participation when you have signed up for the course.
Further Information or Questions:
Please email us at personlig.medicin@rsyd.dk